Welcome back Rounds Table Listeners!
We are back today with our Classic Rapid Fire Podcast!
This week, Drs. Emily Hughes and Justin Boyle discuss two recent papers exploring a novel agent, Zilebesiran, in the management of hypertension and the use of Semaglutide in patients that have obesity and heart failure with preserved ejection fraction. Two papers, here we go!
-
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension (0:00 – 10:10).
-
Semaglutide in Patients with Heart Failurewith Preserved Ejection Fraction and Obesity (10:10 – 20:18).
And for the Good Stuff:
-
The Boy and the Heron (20:18 – 21:02).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
